Colorectal cancer: open trials in Sweden

47 open trials have a site in Sweden. Registry data; only the trial team decides who can take part.

NCT06662786
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Region Skane Skanes Universitetssjukhus, Lund · Karolinska University Hospital, Solna · Soedersjukhuset AB, Stockholm · Uppsala University Hospital, Uppsala
Registry updated 2026-11-03
NCT06750094
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Region Skane Skanes Universitetssjukhus, Lund · Karolinska University Hospital, Solna · Soedersjukhuset AB, Stockholm · Uppsala University Hospital, Uppsala
Registry updated 2026-11-03
NCT07909148
Parastomal Hernia at 1 and 3 Years: Radiological Incidence, Progression, and Impact on Quality of Life
Research · Region Skane
Region Skåne, Skåne University Hospital, Malmö
Registry updated 2026-11-02
NCT07221357
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
Trial Treatment · Phase 2/3 · Bristol-Myers Squibb
Sahlgrenska University Hospital-Vaestra Goetalandsregionen, Goteborg · Region Skane Skanes Universitetssjukhus, Lund · Karolinska University Hospital, Solna
Registry updated 2026-10-23
NCT07862673
Efficacy of a Novel High Intensive Percutaneous Tibial Nerve Stimulation on Faecal Incontinence in Patients With Low Anterior Resection Cancer Syndrome After Rectal Cancer Surgery
Trial Treatment · Region Skane
Department of Surgery. Pelvic Floor Centre, Malmö
Registry updated 2026-10-23
NCT06885034
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
Trial Treatment · Phase 1/2 · GlaxoSmithKline
Gothenburg · Lund · Stockholm · Uppsala
Registry updated 2026-10-19
NCT07881549
Protein Signature Based Screening of Colorectal Adenomas and Cancer
Research · Region Skane
Skåne University Hopsital, Malmö, Malmö
Registry updated 2026-10-19
NCT07535112
A Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D Mutation
Trial Treatment · Phase 1 · Bayer
Karolinska Universitetssjukhuset - Solna - Fas I-enheten Solna CKC, Stockholm
Registry updated 2026-10-05
NCT06719206
Reduce Sedentary Behavior During Cancer Treatment - the RedSedCan Study
Trial Treatment · Mälardalen University
Akademiska sjukhuset, Uppsala · Västmanlands sjukhus, Västerås
Registry updated 2026-10-01
2025-521045-24-00
Personalizing chemotherapy selection after surgery for patients with stage III colorectal cancer using a blood test
Trial Treatment · Phase 3 · Unicancer
Sahlgrenska University Hospital-Vaestra Goetalandsregionen, Goteborg · Karolinska University Hospital, Huddinge · University Of Skane, Malmo · Soedersjukhuset AB, Stockholm · Uppsala University Hospital, Uppsala
Registry updated 2026-09-28
NCT07213609
A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
Trial Treatment · Phase 1/2 · GlaxoSmithKline
Lund · Stockholm · Uppsala
Registry updated 2026-09-16
NCT06333392
Total Underwater Colonoscopy (TUC) for Improved Colorectal Cancer Screening: A Randomized Controlled Trial
Trial Treatment · Vestre Viken Hospital Trust
Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden, Department of Medicine, Geriatrics and Emergency Care Mölndal, Gothenburg
Registry updated 2026-09-04
NCT06252649
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
Trial Treatment · Phase 3 · Amgen
Soedersjukhuset, Stockholm
Registry updated 2026-09-03
NCT07766044
A One-year Follow-up of Incisional Hernia Formation Between Device Assisted and Manual Laparotomy Closure
Trial Treatment · Suturion AB
Helsingborg hospital, Helsingborg
Registry updated 2026-09-02
NCT04525989
Preoperative Short-Course Radiation Therapy With PROtons Compared to Photons In High-Risk RECTal Cancer (PRORECT)
Trial Treatment · Alexander Valdman
Gävle Hospital, Gävle · Sahlgrenska University Hospital, Gothenburg · Linkoping University Hospital, Linköping · Skåne University Hospital, Lund · Stockholm South General Hospital, Stockholm · Karolinska University Hospital, Theme Cancer, Dept of Pelvic cancer, Stockholm · Sundsvall Hospital, Sundsvall · University Hospital of Umeå, Umeå · Uppsala University Hospital, Uppsala
Registry updated 2026-08-10
NCT06501053
Contact Radiotherapy for Rectal Cancer
Trial Treatment · Alexander Valdman
Karolinska University Hospital, Theme Cancer, Dept of Pelvic cancer, Stockholm · Uppsala University Hospital, Colorectal Surgery, Uppsala
Registry updated 2026-08-10
2022-502352-31-00
Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Subjects With Metastatic Colorectal Cancer With KRAS p.G12C Mutation (CodeBreaK 301)
Trial Treatment · Phase 3 · Amgen Inc.
Soedersjukhuset AB, Stockholm
Registry updated 2026-07-30
NCT06131840
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Trial Treatment · Phase 1 · Seagen, a wholly owned subsidiary of Pfizer
Karolinska University Hospital, Solna
Registry updated 2026-07-22
2026-526122-41-00
COLOVERT – Conversion therapy in colorectal cancer with peritoneal metastases not amenable to upfront cytoreductive surgery and HIPEC: a phase II “pick-the-winner” open-label randomized trial
Trial Treatment · Phase 2 · Uppsala University Hospital
Sahlgrenska University Hospital-Vaestra Goetalandsregionen, Gothenburg · Region Skane Skanes Universitetssjukhus, Malmo · Karolinska University Hospital, Solna · Uppsala University Hospital, Uppsala
Registry updated 2026-07-15
NCT07219238
Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)
Trial Treatment · Phase 2/3 · GE Healthcare
Karolinska University Hospital, Solna
Registry updated 2026-06-17
2025-522955-25-00
Next generation StaR-TREC
Trial Treatment · Phase 4 · Vaestra Goetalandsregionen
Sahlgrenska University Hospital-Vaestra Goetalandsregionen, Gothenburg · Region Skane Skanes Universitetssjukhus, Malmo · Soedersjukhuset AB, Stockholm
Registry updated 2026-05-06
NCT06111105
GUIDE.MRD-01-CRC: Clinical Validation and Benchmarking of Top Performing ctDNA Diagnostics - Colorectal Cancer
Research · Claus Lindbjerg Andersen
Karolinska University Hospital, Huddinge
Registry updated 2026-05-04
NCT05726136
Fluid Challenge and Plasma Volume, During Surgery
Trial Treatment · Phase 4 · Joachim Zdolsek
Vrinnevi Hospital, Norrköping
Registry updated 2026-04-30
NCT05102981
Function and Quality of Life After Emergency vs Planned Creation of a Stoma
Research · Eva Haglind, MD, PhD, professor
Gothenburg University, Sahlgrenska Academy, Institute of Cinical Sciences, Department of Surgery, Gothenburg
Registry updated 2026-04-27
NCT04450758
Acute Colon Resection Versus Bridge to Colon Surgery With Stent or Stoma
Research · Skane University Hospital
Göteborg University, Gothenburg
Registry updated 2026-04-23

All Colorectal cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error